Matthew Lavelle, MD
Adult Reconstructive Orthopaedic Surgery · Boynton Beach, FLNPI 1437511284
Payments from drug & device makers
What this record shows
The money is spread across several categories — education (58.9%), food and beverage and travel and lodging — rather than concentrated in one kind of arrangement. Smith+Nephew accounts for 70.4% of it on its own, with 6 other manufacturers making up the rest. Reporting peaked in 2022 at $7,138 and has fallen 59.8% since, to $2,870 in 2025.
Across 93 payments — averaging $225.68 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Smith+Nephew$15K
- Zimmer Biomet$4K
- Stryker$2K
- Medical Device Business Services, Inc.$355
- Johnson & Johnson$194
- Bone Support Inc.$145
- plus $74 from 1 others
What the payments were for
- Travel & lodging$2,27911%
- Food & beverage$6,35430%
- Education$12,35559%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Smith+Nephew | 41 | $14,786 |
| Zimmer Biomet | 20 | $3,539 |
| Stryker | 24 | $1,894 |
| Medical Device Business Services, Inc. | 2 | $355 |
| Johnson & Johnson | 4 | $194 |
| Bone Support Inc. | 1 | $145 |
| KCI USA, Inc. | 1 | $74 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Journey II$2,236
- MAKO$1,254
- REAL INTELLIGENCE$1,205
- Legion Revision$1,202
- Persona$1,158
- ROSA$694
- Velys$250
- CERAMENTBONE VOID FILLER$145
- CERAMENT G$145
- EVOS$143
- CANNULATED SCREWS$143
- TRIGEN InterTAN$143
- TRIGEN Meta-Nail$143
- MAVERICK$143
- OR3O Dual Mobility$135
- POLARSTEM$135
- GAMMA$135
- ATTUNE$125
- A.L.P.S.$110
How this compares
$20,988 in reported general payments places this provider in the 60th percentile of 96 adult reconstructive orthopaedic surgery providers in Florida.
See all adult reconstructive orthopaedic surgery providers in Florida →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Meloxicam | 352 | $814 |
| Methylprednisolone | 63 | $389 |
| Ondansetron OdtOndansetron | 45 | $257 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 47 | $233 |
| Celecoxib | 14 | $143 |
| Cephalexin | 21 | $127 |
| Tramadol Hcl | 45 | $92 |
| Oxycodone Hcl | 14 | $54 |
Paid to pharmacies, not to this prescriber.
Other adult reconstructive orthopaedic surgery in Boynton Beach
- Elvis GrandicBoynton Beach$102K
- Carlos LaverniaMiami$5.4M
- Juan SuarezMiami$3.9M
- John RedmondJacksonville$987K
- Gavan DuffyJacksonville$543K
- Timothy van de LeurSummerfield$511K
- Edward StolarskiSarasota$445K
- Andrew NoblePalm Beach Gardens$308K
- Raul GostheMiami$252K
- Chancellor GrayGainesville$228K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.